載入...
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes...
Na minha lista:
| 發表在: | Mol Med |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6584997/ https://ncbi.nlm.nih.gov/pubmed/31221082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-019-0098-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|